1
|
Rühm W, Pihet P, Schuhmacher H. The European Radiation Dosimetry Group-a 40 year success story. RADIATION PROTECTION DOSIMETRY 2023; 199:1659-1669. [PMID: 37819296 DOI: 10.1093/rpd/ncac193] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/28/2022] [Revised: 08/08/2022] [Accepted: 09/02/2022] [Indexed: 10/13/2023]
Abstract
The European Radiation Dosimetry Group (EURADOS) was founded in 1982. Since then, the group has continuously developed and is currently a network of 80 institutions and more than 600 individual scientists across Europe, including exchange with the scientific community outside of Europe. EURADOS supports research and development of dosimetry and harmonising dosimetric practices. This paper describes the major milestones in the history of the organization. It starts from the very beginning when the idea was born and describes periods during which the role and strategy of the network had to be defined, elaborated and refined. Finally, it ends to date where EURADOS appears as an independent self-sustainable association, which is a reliable partner for various international organisations in radiation research and radiation protection. Major activities of EURADOS are highlighted such as (1) establishment and coordination of Working Groups, (2) regular organization of dosimetric intercomparisons for quality assurance of dosimetry procedures, (3) development and organization of education and training events, and (4) contributions towards the development of strategic and integrated radiation research in Europe.
Collapse
Affiliation(s)
- Werner Rühm
- Helmholtz Zentrum München, Institute of Radiation Medicine, Neuherberg 85764, Germany
| | | | | |
Collapse
|
2
|
Harrison RM, Ainsbury E, Alves J, Bottollier-Depois JF, Breustedt B, Caresana M, Clairand I, Fantuzzi E, Fattibene P, Gilvin P, Hupe O, Knežević Ž, Lopez MA, Olko P, Olšovcová V, Rabus H, Rühm W, Silari M, Stolarczyk L, Tanner R, Vanhavere F, Vargas A, Woda C. EURADOS STRATEGIC RESEARCH AGENDA 2020: VISION FOR THE DOSIMETRY OF IONISING RADIATION. RADIATION PROTECTION DOSIMETRY 2021; 194:42-56. [PMID: 33989429 PMCID: PMC8165425 DOI: 10.1093/rpd/ncab063] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/07/2021] [Revised: 02/28/2021] [Accepted: 04/06/2021] [Indexed: 05/02/2023]
Abstract
Since 2012, the European Radiation Dosimetry Group (EURADOS) has developed its Strategic Research Agenda (SRA), which contributes to the identification of future research needs in radiation dosimetry in Europe. Continued scientific developments in this field necessitate regular updates and, consequently, this paper summarises the latest revision of the SRA, with input regarding the state of the art and vision for the future contributed by EURADOS Working Groups and through a stakeholder workshop. Five visions define key issues in dosimetry research that are considered important over at least the next decade. They include scientific objectives and developments in (i) updated fundamental dose concepts and quantities, (ii) improved radiation risk estimates deduced from epidemiological cohorts, (iii) efficient dose assessment for radiological emergencies, (iv) integrated personalised dosimetry in medical applications and (v) improved radiation protection of workers and the public. This SRA will be used as a guideline for future activities of EURADOS Working Groups but can also be used as guidance for research in radiation dosimetry by the wider community. It will also be used as input for a general European research roadmap for radiation protection, following similar previous contributions to the European Joint Programme for the Integration of Radiation Protection Research, under the Horizon 2020 programme (CONCERT). The full version of the SRA is available as a EURADOS report (www.eurados.org).
Collapse
Affiliation(s)
| | - E Ainsbury
- Public Health England, Chilton, Didcot, UK
| | - J Alves
- Instituto Superior Técnico (IST), CTN, Lisboa, Portugal
| | - J-F Bottollier-Depois
- Institut de Radioprotection et de Sûreté Nucléaire (IRSN), Fontenay-aux-Roses Cedex, France
| | - B Breustedt
- Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany
| | | | - I Clairand
- Institut de Radioprotection et de Sûreté Nucléaire (IRSN), Fontenay-aux-Roses Cedex, France
| | - E Fantuzzi
- ENEA - Radiation Protection Institute, Bologna, Italy
| | - P Fattibene
- Istituto Superiore di Sanità (ISS), Rome, Italy
| | - P Gilvin
- Public Health England, Chilton, Didcot, UK
| | - O Hupe
- Physikalisch Technische Bundesanstalt (PTB), Braunschweig and Berlin, Germany
| | - Ž Knežević
- Ruđer Bošković Institute (RBI), Zagreb, Croatia
| | - M A Lopez
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain
| | - P Olko
- Instytut Fizyki Jądrowej Polskiej Akademii Nauk (IFJ PAN), Kraków, Poland
| | - V Olšovcová
- ELI Beamlines, Institute of Physics, Czech Academy of Sciences, Dolní Břežany, Czech Republic
| | - H Rabus
- Physikalisch Technische Bundesanstalt (PTB), Braunschweig and Berlin, Germany
| | - W Rühm
- Helmholtz Zentrum München, Institute of Radiation Medicine, Neuherberg, Germany
| | - M Silari
- CERN, 1211 Geneva 23, Switzerland
| | - L Stolarczyk
- Danish Centre for Particle Therapy, Aarhus, Denmark
- Instytut Fizyki Jądrowej Polskiej Akademii Nauk (IFJ PAN), Kraków, Poland
| | - R Tanner
- Public Health England, Chilton, Didcot, UK
| | - F Vanhavere
- Belgian Nuclear Research Centre (SCK-CEN), Mol, Belgium
| | - A Vargas
- Institute of Energy Technologies, Universitat Politecnica de Catalunya, Barcelona, Spain
| | - C Woda
- Helmholtz Zentrum München, Institute of Radiation Medicine, Neuherberg, Germany
| |
Collapse
|
3
|
Rühm W, Ainsbury E, Breustedt B, Caresana M, Gilvin P, Knežević Ž, Rabus H, Stolarczyk L, Vargas A, Bottollier-Depois J, Harrison R, Lopez M, Stadtmann H, Tanner R, Vanhavere F, Woda C, Clairand I, Fantuzzi E, Fattibene P, Hupe O, Olko P, Olšovcová V, Schuhmacher H, Alves J, Miljanic S. The European radiation dosimetry group – Review of recent scientific achievements. Radiat Phys Chem Oxf Engl 1993 2020. [DOI: 10.1016/j.radphyschem.2019.108514] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
4
|
Rühm W, Breckow J, Dietze G, Friedl A, Greinert R, Jacob P, Kistinger S, Michel R, Müller WU, Otten H, Streffer C, Weiss W. Dose limits for occupational exposure to ionising radiation and genotoxic carcinogens: a German perspective. RADIATION AND ENVIRONMENTAL BIOPHYSICS 2020; 59:9-27. [PMID: 31677018 DOI: 10.1007/s00411-019-00817-x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/30/2019] [Accepted: 10/14/2019] [Indexed: 06/10/2023]
Abstract
This paper summarises the view of the German Commission on Radiological Protection ("Strahlenschutzkommission", SSK) on the rationale behind the currently valid dose limits and dose constraints for workers recommended by the International Commission on Radiological Protection (ICRP). The paper includes a discussion of the reasoning behind current dose limits followed by a discussion of the detriment used by ICRP as a measure for stochastic health effects. Studies on radiation-induced cancer are reviewed because this endpoint represents the most important contribution to detriment. Recent findings on radiation-induced circulatory disease that are currently not included in detriment calculation are also reviewed. It appeared that for detriment calculations the contribution of circulatory diseases plays only a secondary role, although the uncertainties involved in their risk estimates are considerable. These discussions are complemented by a review of the procedures currently in use in Germany, or in discussion elsewhere, to define limits for genotoxic carcinogens. To put these concepts in perspective, actual occupational radiation exposures are exemplified with data from Germany, for the year 2012, and regulations in Germany are compared to the recommendations issued by ICRP. Conclusions include, among others, considerations on radiation protection concepts currently in use and recommendations of the SSK on the limitation of annual effective dose and effective dose cumulated over a whole working life.
Collapse
Affiliation(s)
- Werner Rühm
- Helmholtz Zentrum München, Institute of Radiation Therapy, Ingolstädter Landstr. 1, 85764, Oberschleißheim, Germany.
| | | | - Günter Dietze
- Physikalisch-Technische Bundesanstalt, Braunschweig, Germany
| | - Anna Friedl
- Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany
| | | | - Peter Jacob
- Helmholtz Zentrum München, Neuherberg, Germany
| | | | | | | | - Heinz Otten
- Deutsche Gesetzliche Unfallversicherung, Berlin, Germany
| | | | | |
Collapse
|
5
|
Affiliation(s)
- Andrzej Wojcik
- Centre for Radiation Protection Research, Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden
- Department of Radiobiology and Immunology, Institute of Biology, Jan Kochanowski University, Kielce, Poland
| | - Mats Harms-Ringdahl
- Centre for Radiation Protection Research, Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden
| |
Collapse
|